by bmi_wpadmin | Jul 14, 2022 | BayMedica
Jerry P. Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, is interviewed by Shadd Dales of The Dales Report to talk about the recent B2B sales launch of rare cannabinoid #tetrahydrocannabivarin #d9 #THCV into the health and wellness sector....
by bmi_wpadmin | Jun 2, 2022 | BayMedica, Cannabinoids
As everyone in the cannabis and hemp industries knows, supply chain issues can be a major threat to business. The pandemic has unleashed chaos on supply chains across the globe, and the cannabis industry has not been spared. While the COVID-induced supply chain issues...
Recent Comments